Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03925597 · ClinicalTrials.gov registry record · NA
Multiomic Signatures of Microbial Metabolites Following Prebiotic Fiber Supplementation
A NA study of Prebiotics, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03925597: Active NA study of Prebiotics, sponsored by Stanford University.
NCT03925597 is a NA study of Prebiotics that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03925597, a NA study of Prebiotics, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose a comprehensive, multiomic study that will integrate longitudinal data associating changes in specific gut bacteria and host in response to prebiotic fiber supplementation. These data will guide the development of an integrative biological signature relating bacterial-derived metabolites with biological outcome in the host. The open sharing of data generated by the proposed research represents a significant public resource that will support and accelerate future novel studies.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Fiber cycles ARM 1
- DIETARY_SUPPLEMENT Fiber cycles ARM 2
- DIETARY_SUPPLEMENT Fiber cycles ARM 3
- DIETARY_SUPPLEMENT Fiber cycles ARM 4
- DIETARY_SUPPLEMENT Fiber cycles ARM 5
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-01-21 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What the registry record for NCT03925597 still lists
NCT03925597 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Prebiotics appearing as the primary indexed condition, and to 5 interventions - of which Fiber cycles ARM 1 is the first listed.
NCT03925597 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03925597 about?
NCT03925597 is a clinical study titled "Multiomic Signatures of Microbial Metabolites Following Prebiotic Fiber Supplementation". The investigators propose a comprehensive, multiomic study that will integrate longitudinal data associating changes in specific gut bacteria and host in response to prebiotic fiber supplementation. These data will guide the development of an integrative biological signature relating bacterial-deriv...
What is the current status of trial NCT03925597?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2020-01-21. Estimated completion is 2025-08-31.
What conditions does trial NCT03925597 study?
This clinical trial studies the following conditions: Prebiotics.
What interventions are being tested in trial NCT03925597?
The interventions under investigation include: Fiber cycles ARM 1 (DIETARY_SUPPLEMENT), Fiber cycles ARM 2 (DIETARY_SUPPLEMENT), Fiber cycles ARM 3 (DIETARY_SUPPLEMENT), Fiber cycles ARM 4 (DIETARY_SUPPLEMENT), Fiber cycles ARM 5 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03925597?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03925597 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03925597's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI